Nutrition & DietPress Release

Longevity Diet Low in Methionine Cuts Fat and Frailty in Aging Mice

A modified Mediterranean diet with low protein and tuned methionine levels boosted healthspan and slashed body fat in older mice.

Friday, July 10, 2026 1 view
Published in ScienceDaily Nutrition
Article visualization: Longevity Diet Low in Methionine Cuts Fat and Frailty in Aging Mice

Summary

Researchers at USC found that a modified Mediterranean-style diet low in protein and carefully adjusted in the amino acid methionine helped aging mice live healthier lives. Mice on this diet carried less body fat, showed fewer signs of frailty, and had better metabolic markers than mice on standard, Western, or ketogenic diets. Importantly, these benefits appeared despite the mice eating more food. An analysis of dietary data from over 200,000 people found that those eating more plant-based diets had lower rates of obesity and Type 2 diabetes. The findings suggest that the type of protein you eat — and its amino acid composition — may matter more than total protein quantity for long-term metabolic health.

Detailed Summary

A new study published in Cell Metabolism suggests that the composition of dietary protein, not just the amount, plays a critical role in healthy aging. Researchers from the University of Southern California, led by longevity scientist Valter Longo, tested a modified Mediterranean-style diet on aging mice and found striking improvements in healthspan, body composition, and frailty markers.

The diet, called LDMM, was low in overall protein but supplemented with methionine — an essential amino acid found in eggs, meat, and dairy that is naturally lower in plant foods. Mice aged 20 months were split across four diets: standard, Western high-fat, ketogenic, and LDMM. The LDMM group outperformed all others, showing less body fat and reduced frailty despite consuming more total food — a notable metabolic finding suggesting the diet actively shifts how the body uses energy.

Biological markers improved significantly in LDMM mice, including elevated GLP-1 levels and other signaling molecules linked to metabolic regulation and aging. This hormonal coordination across multiple pathways was described by the researchers as particularly compelling, as GLP-1 is the same target as popular weight-loss drugs like semaglutide.

To complement the animal data, the team analyzed dietary and health records from over 200,000 people through a collaboration with the University of Toronto and Harvard University. Women and men who ate more plant-centered diets showed lower rates of obesity and Type 2 diabetes, lending human relevance to the mouse findings.

The practical implication is that a mostly vegan or vegetarian diet with fish, supplemented with small strategic amounts of methionine, may offer a dietary framework for extending healthy lifespan. However, the mouse-to-human translation remains unproven in controlled trials, and the optimal methionine dose for humans is not yet established. Independent clinical validation is needed before firm dietary recommendations can be made.

Key Findings

  • Mice on a low-protein, methionine-supplemented Mediterranean diet showed reduced body fat and frailty compared to Western and keto diets.
  • Metabolic benefits occurred even though LDMM mice ate more food, suggesting a shift in energy metabolism rather than caloric restriction.
  • GLP-1 and multiple metabolic hormones were elevated in LDMM mice, mirroring pathways targeted by weight-loss drugs like semaglutide.
  • Analysis of 200,000+ people linked higher plant protein intake to lower obesity and Type 2 diabetes rates.
  • Amino acid composition — not total protein quantity — may be the key lever for metabolic and longevity interventions.

Methodology

This is a research summary based on a peer-reviewed study published in Cell Metabolism from USC, with human data from a 200,000-person cohort analyzed in collaboration with Harvard and University of Toronto. The animal study is controlled but limited to mice; the human component is observational and cannot establish causation.

Study Limitations

Mouse findings do not directly translate to humans, and no controlled clinical trial has yet tested the LDMM protocol in people. The human data is observational, meaning confounding lifestyle factors cannot be ruled out. The precise methionine supplementation dose used in mice has no validated human equivalent yet.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: